Want to join the conversation?
$PFE announces positive top-line results of two Phase 3 studies of oral tofacitinib (XELJANZ) for the treatment of ulcerative colitis. Both studies, OCTAVE Induction 1 and OCTAVE Induction 2, achieved their primary endpoints measured by the proportion of patients in remission at week 8 versus placebo.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!